Incidence of herpes zoster among individuals vaccinated against COVID-19 and/or those who have contracted the virus: a cross-sectional analysis - Scorecard - MDSpire
Advertisement
Incidence of herpes zoster among individuals vaccinated against COVID-19 and/or those who have contracted the virus: a cross-sectional analysis
Clinical Scorecard: Incidence of herpes zoster among individuals vaccinated against COVID-19 and/or those who have contracted the virus: a cross-sectional analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Reactivation of Varicella zoster virus (VZV) after primary infection, potentially influenced by COVID-19 or vaccination.
Target Population
Care Setting
Key Highlights
Increased incidence of herpes zoster post-COVID-19 vaccination and infection.
Reactivation of VZV may occur spontaneously or due to stress, fever, or immunosuppression.
Study utilized a 20-question survey to assess incidence and symptoms.
Further research needed to understand long-term effects of COVID-19 vaccines on herpes zoster incidence.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Follow-up on patients with a history of COVID-19 or vaccination for herpes zoster symptoms, especially in those with prior herpes zoster.
Risks
Patient & Prescribing Data
Further research needed to understand long-term effects of COVID-19 vaccines on herpes zoster incidence and potential preventive measures.
Clinical Best Practices
Educate patients about the risk of herpes zoster post-vaccination.
Encourage reporting of any herpes zoster symptoms following vaccination or COVID-19 infection.
Consider recommending herpes zoster vaccination for at-risk populations.
Protection against spread appeared strongest within 6 months of vaccination, while exposed vaccinated contacts showed no measurable reduction in infection risk.
